AstraZeneca braced for pay revolt as sales disappoint

Neville White, head of SRI policy and research at EdenTree Investment Management, speaks to The Telegraph ahead of the AstraZeneca AGM. He states EdenTree will be voting against the remuneration report because of concerns around excessive bonus levels.

Link

top